Douglas H. Shulman - 20 Nov 2025 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Reporting relationship
Director
Issuer ticker
CVS
Reported as of
20 Nov 2025
Net transaction value
+$125,618
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
21 Nov 2025, 17:47:50 UTC
Prior SEC filing
05 Nov 2025
Next SEC filing
02 Jan 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Douglas H. Shulman

Key filing fact

Douglas H. Shulman filed Form 4 for CVS HEALTH Corp (CVS) on 21 Nov 2025.

Key facts

  • This page summarizes Douglas H. Shulman's Form 4 filing for CVS HEALTH Corp (CVS).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 21 Nov 2025, 17:47.

Change

  • Previous filing in this sequence was filed on 05 Nov 2025.
  • Current net transaction value: +$125,618.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001726926 Primary reporting owner

Shulman Douglas H.

Relationship
Director
Address
ONE CVS DRIVE, WOONSOCKET
Signature
/s/ Douglas H. Shulman
Signature date
21 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CVS transaction

Common Stock

Award

Transaction value
$125,618
Shares
+1,652
Change %
+39%
Price
$76.04
Shares after
5,929
Date
20 Nov 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .